Seres Therapeutics Stock Forecast
Stronger technical forecast for Seres Therapeutics stock price after Tuesday trading.
(Updated on Jul 02, 2024)
The Seres Therapeutics stock price fell by -2.91% on the last day (Tuesday, 2nd Jul 2024) from $0.722 to $0.701. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.53% from a day low at $0.700 to a day high of $0.753. The price has been going up and down for this period, and there has been a 4.49% gain for the last 2 weeks. Volume has increased on the last day by 363 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $1.52 million.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.599 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.12% during the next 3 months and, with a 90% probability hold a price between $0.624 and $1.27 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
MCRB Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Seres Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.742 and $0.85. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, May 06, 2024, and so far it has fallen -41.09%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Seres Therapeutics stock
Seres Therapeutics finds support from accumulated volume at $0.689 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0527 between high and low, or 7.53%. For the last week, the stock has had daily average volatility of 8.50%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (MCRB) For The Upcoming Trading Day Of Wednesday 3rd
For the upcoming trading day on Wednesday, 3rd we expect Seres Therapeutics to open at $0.718, and during the day (based on 14 day Average True Range), to move between $0.608 and $0.794, which gives a possible trading interval of +/-$0.0929 (+/-13.25%) up or down from last closing price. If Seres Therapeutics takes out the full calculated possible swing range there will be an estimated 26.50% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.689 (1.65%) than the resistance at $0.740 (5.58%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Seres Therapeutics stock A Buy?
The Seres Therapeutics stock holds several negative signals and despite the positive trend, we believe Seres Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score: -1.020 Sell Candidate Upgraded
Predicted Opening Price for Seres Therapeutics of Wednesday, July 3, 2024
| Fair opening price July 3, 2024 | Current price |
|---|---|
| $0.718 ( 2.41%) | $0.701 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for MCRB
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.771 | 9.93% |
| R2 | 0.750 | 7.06% |
| R1 | 0.738 | 5.28% |
| Price | 0.701 | |
| S1 | 0.698 | -0.461% |
| S2 | 0.685 | -2.24% |
| S3 | 0.665 | -5.11% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.85 | 21.70% |
| R2 | 0.749 | 6.90% |
| R1 | 0.740 | 5.58% |
| Price | 0.701 | |
| S1 | 0.689 | -1.65% |
| S2 | 0.627 | -10.51% |
| S3 | 0.614 | -12.41% |
FAQ
Click here for our free guide on how to buy Seres Therapeutics Stock.
